Target intelligence / Profile preview

Central nociceptive processing pathways

Molecular classification
Other
01

Overview

Central nociceptive processing pathways encompass the hierarchical network of neurons and signaling systems in the spinal cord and brain responsible for the transmission, modulation, and interpretation of pain signals. These pathways include the dorsal horn of the spinal cord, where primary afferent fibers synapse, and ascending tracts such as the spinothalamic tract that project to the thalamus and cortical areas like the somatosensory cortex and anterior cingulate cortex (StatPearls, 2023, NBK539789). A critical feature of these pathways is their plasticity; persistent noxious input can lead to central sensitization, a state of heightened synaptic efficacy and reduced inhibitory control that drives chronic pain syndromes (Nature Reviews Neuroscience, 2009, 10(3):199-212). Therapeutic intervention in these pathways is diverse, targeting various molecular components such as Mu-opioid receptors, NMDA receptors, and voltage-gated calcium channels to attenuate signal transmission or enhance descending inhibitory control from the brainstem (British Journal of Anaesthesia, 2013, 13(5):167-173). Understanding these pathways is essential for biotech analysts as they represent the physiological framework for most analgesic drug development, particularly for conditions where the pathology resides within the central nervous system rather than peripheral tissue damage.

Other names
Central pain pathwaysAscending nociceptive pathwaysCentral pain processing systemNociceptive system
02

Mechanism of action

Modulation of synaptic transmission and neuronal excitability within the spinal cord and brain, primarily through the inhibition of excitatory neurotransmitters or the enhancement of descending inhibitory pathways.

03

Biological functions

NociceptionSensory perceptionSignal transductionNeuromodulation
04

Disease associations

Chronic painNeuropathic painCentral sensitizationFibromyalgiaHyperalgesiaAllodynia
05

Safety considerations

Central nervous system depressionRisk of dependence and addictionCognitive impairmentSedationToleranceRespiratory depression
06

Interacting drugs

Morphine

7 more in the full profile.

07

Biomarkers

Quantitative Sensory Testing (QST)Functional MRI (fMRI) pain signaturesCerebrospinal fluid substance P levelsElectroencephalography (EEG) power spectra

Beyond the preview

Go deeper on Central nociceptive processing pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central nociceptive processing pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call